Rhythm (RYTM) news
Recent news
Rhythm Pharmaceuticals, Inc.: Deutsche Bank initiates coverage with hold rating and target price $120
AInvest Wire · 3d agoRhythm Biosciences FY prelim loss from ordinary activities after tax attributable A$5.9 mln
Rhythm Biosciences Limited (ASX: RHY) reported a preliminary loss from ordinary activities after tax of A$5.9 million for the fiscal year, according to its preliminary financial results. The loss reflects ongoing operational challenges and expenses associated with the company’s research and…
AInvest Wire · 4d agoRhythm Biosciences - Appoints Maureen Baker and Carl Stubbings as non-executive directors effective 27 August 2026
Rhythm Biosciences Limited (ASX: RHY) has announced the appointment of Maureen Baker and Carl Stubbings as non-executive directors, effective 27 August 2026 . This addition to the board follows the company’s ongoing efforts to strengthen its governance and strategic direction. Non-executive…
AInvest Wire · 5d agoRhythm Pharmaceuticals reports MHLW approval of IMCIVREE
AInvest Wire · 7d agoRhythm Pharmaceuticals: IMCIVREE launch in Japan expected by end of 2026 pending pricing
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.